GENE: Prakiraan rega marang bathi gtglabs.com

GENE (gtglabs.com) - tandha merek perusahaan

The forward P/E ratio of Genetic Technologies (GENE) reflects the impact of geopolitical barriers and logistics disruptions on diagnostics exports, with the value holding at 0.00. Stability is supported by the scaling of cancer test sales, which reduces unit costs. High pricing power, driven by the uniqueness of polygenic health risk analysis, creates a foundation of resilience for Genetic Technologies (GENE).

Kapitalisasi marang proyeksi bathi: Genetic Technologies (GENE) kanggo 04.07.2022 - 26.10.2024

Rincian analitis lan laporan data perusahaan GTG Labs (GENE)

- nilai saham lan prakiraan konsensus rega:
Bagan rega Genetic Technologies|GENE - Bagan rega target
- informasi kapitalisasi pasar:
Biji pasar Genetic Technologies Ltd|GENE - Total Nilai Perusahaan
- statistik nilai buku emiten:
Aset Bersih saben Siji Saham Genetic Technologies|GENE - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku gtglabs.com|GENE - Gunggung Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas Genetic Technologies|GENE - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Genetic Technologies|GENE - Tanggungan utang total perusahaan|Utang-utang marang kapitalisasi buku Genetic Technologies Ltd|GENE - Utang jangka dawa|Utang jangka cendhak perusahaan Genetic Technologies|Rasio cepet gtglabs.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
GENE - Penghasilan resik perusahaan|Bathi mangsa ngarep Genetic Technologies|GENE - Rasio rega pasar marang bathi resik|Pangali Forward P/E Genetic Technologies|GENE - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Genetic Technologies Ltd|GENE - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Genetic Technologies|GENE - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan gtglabs.com|GENE - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Genetic Technologies
Analisis wiwitan perusahaan:Genetic Technologies Limited
Produk mawa merek GTG Labs

The forward P/E reflects the ratio of the asset's current market value to expected earnings, allowing for an assessment of the premium paid for potential revenue growth. By analyzing the forward P/E of Genetic Technologies (GENE), an investor determines the fairness of the price considering the implementation of diagnostic panels in clinics, which creates a sustainable revenue stream through the use of Genetic Technologies (GENE) patented biomarkers.

Pesaing Genetic Technologies (GENE)

Rega marang bathi mangsa ngarep Agilent (A)|Rega marang bathi mangsa ngarep DGX (Quest Diagnostics Inc.)|Illumina Corp - Prakiraan rega marang bathi|Exact Sciences Inc. (EXAS) - Rasio prakiraan rega marang bathi|RVTY - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi bio-rad.com BIO|NNNN: Pangali Forward P/E|SHC - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep QuidelOrtho Corp|OPKO Health Corp. (OPK) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E CDNA|maravai.com (MRVI) - Pangali forward rega marang bathi|Pangali Forward P/E FLGT (Fulgent Genetics)|Standard BioTools Inc (LAB) - Rasio prakiraan rega marang bathi|CTKB - Rega marang bathi mangsa ngarep|OSUR (OraSure Corp) - Rasio rega marang bathi mangsa ngarep|XGN: Pangali Forward P/E|Rasio prakiraan rega marang bathi mdxhealth.com (MDXH)|Prakiraan rega marang bathi LUCD|PRE (Prenetics Global Ltd) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E IMDX|Kapitalisasi marang proyeksi bathi trinitybiotech.com|Pangali Forward P/E PRPH (ProPhase Labs, Inc.)|AIMD - Prakiraan rega marang bathi|CODX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi HSCS (Heart Test Laboratories, Inc.)|BMRA (Biomerica, Inc) - Prakiraan rega marang bathi|CDIO: Rasio kapitalisasi marang bathi mangsa ngarep|ONCO (Onconetix, Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi viraxbiolabs.com VRAX|Pangali Forward P/E BJDX|Prakiraan rega marang bathi Aspira Women's Health, Inc. AWH|Pangali Forward P/E AXDX (Accelerate Diagnostics, Inc)|Pangali mangsa ngarep rega marang bathi CNTG|ENZ - Rega marang bathi mangsa ngarep|FRES (Fresh2 Group Limited) - Rasio rega marang bathi mangsa ngarep|23andMe (ME) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Psychemedics Corp. (PMD)